Sort
82,697 grants matching “vaccine development”
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,076,274Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI
Engineered bone marrow niche to reconstitute T cell immunity
$2,076,253David T Scadden · Harvard University · U54 · FY2019 · CA
Development of an Optimized Adjuvanted TB Vaccine
$2,076,197Jay Evans · University Of Montana · N01 · FY2022 · AI
SPORE for Translational Approaches to Brain Cancer
$2,076,151Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2024 · CA
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,076,094Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
University of Rochester Wilmot Cancer Institute Support Grant
$2,075,744Jonathan W Friedberg · University Of Rochester · P30 · FY2025 · CA
Northwestern University Clinical Trial Unit
$2,074,541Robert L. Murphy · Northwestern University At Chicago · U01 · FY2010 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2016 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,074,220Stephen A Spector · University Of California, San Diego · UM1 · FY2017 · AI
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody
$2,074,124Soren Bregenholt · Symphogen A/S · U01 · FY2006 · AI
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$2,073,213Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Papillomavirus Virion Proteins and Vaccines
$2,073,048John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Miami Center for AIDS Research
$2,072,126Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2021 · AI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$2,072,034Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2023 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$2,071,775Massachusetts General Hospital · U01 · FY2002 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,071,529Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2022 · AI
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,071,388Dana-Farber Cancer Institute · P01 · FY2003 · CA
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,070,907Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$2,070,362Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2019 · AI
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,069,565Steven Mark Albelda · University Of Pennsylvania · P01 · FY2019 · CA
Malaria Pathogenesis in young children and vaccine discovery
$2,069,553Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
New Animal Models for Tuberculosis
$2,069,412Michelle Linehan · Johns Hopkins University · N01 · FY2009 · AI
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,069,231Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Multivalent display of anthrax toxin inhibitors
$2,068,666Marianne Manchester · Scripps Research Institute, The · P01 · FY2006 · AI
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$2,068,496Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2009 · AI